Clarity Pharmaceuticals closes $25m capital raising
Sydney, Australia 15 December 2020 – Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of $25,000,410. Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, commented, “It has been a pivotal year for Clarity with numerous critical milestones achieved…